Medical devices, healthcare technology and the business of care
510(k) clearance · K262214

Disposable Reflective Marker Spheres (AM-BK115S, AM-BL130S)

Guangzhou Aimooe Technology Co., Ltd. · Decision date Oct 15, 2026

MEDTECHLEDGER EXPLANATIONK262214

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-15 for K262214, a traditional 510(k) from Guangzhou Aimooe Technology Co., Ltd. for Disposable Reflective Marker Spheres (AM-BK115S, AM-BL130S). The device falls under regulation number 882.4560, classification product code HAW, device classification name Neurological Stereotaxic Instrument, with Neurology as the regulation medical specialty and review panel. The application was received 06/30/2026 and was not reviewed by a third party; it was not recorded as a combination product, and no predetermined change control plan was authorized.

SESE means the submission was cleared as substantially equivalent to a predicate; it is not a PMA approval. The public record does not identify the predicate device, the specific materials or dimensional differences between the two model numbers, or any performance data supporting equivalence, so the technical basis for the clearance remains unknown from this source.

The same decision appears in CDRH's listing of 510(k) final decisions rendered since October 01, 2026, published 15 Oct 2026, matching the device name and applicant.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Oct 15, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262214
Regulatory pathway
510(k) premarket notification
Product code
HAW
Decision code
SESE
Decision date
Oct 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Neurological Stereotaxic Instrument.

Product code
HAW
FDA device class
2

FDA decision timeline

  1. K262214 received

    Application receipt date recorded by FDA.

  2. K262214 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HAW

Product / regulatory recordCompanyPathwayDecision dateSource
inomed Medizintechnik GmbH510(k) clearanceNov 6, 2026FDA
Medtronic Navigation510(k) clearanceNov 6, 2026FDA
NeuroAlignK261997
Medivis, Inc.510(k) clearanceOct 26, 2026FDA
Koh Young Technology, Inc.510(k) clearanceSep 10, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Guangzhou Aimooe Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Guangzhou

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records